In addition, a recent report correlated the detection of circulating tumor cells (CTCs) in peripheral blood with the metastatic process of tumors, and PD-L1 is highly expressed in CTCs from patients with advanced head and neck cancer, suggesting that PD-L1+CTC may be a predictive biomarker of response to ICIs [104]. Here, CD274 is linked to head and neck cancer.